Biggest News Aggregation in the World
📰 Genome Sequencing News

Page 35 - Genome Sequencing News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Genome Sequencing. Real-time updates on events, politics, business and more.

1st case of XE Covid-19 variant in India? No evidence yet

After the Brihanmumbai Municipal Corporation today (April 6, 2022) reported India's first case of XE variant of Covid-19 infection in Mumbai, a consortium of government-owned labs, which monitor genomic variations of the virus, have said scientific evidence so far does not indicate it to be so.
South Africa New Delhi Indian Health Ministry Kasturba Hospital Genome Sequencing Lab Genomics Consortium Brihanmumbai Municipal Corporation

BBCNEWS BBC News January 28, 2022 17:22:00

Symptomatic disease for this and the original omicron variant. much more research is needed. they say that the uk is in quite a good position because the amount of genome sequencing carried out here and they can react and respond quite quickly. infections are still at high rates and people should still be cautious as restrictions are eased, so consider still wearing masks to get your vaccinations and to carry on testing regularly.— your vaccinations and to carry on testing regularly. thank you...
Omicron Coronavirus Variant Genome Sequencing Nick Eardley Tomos Morgan Mark Drakeford Road Map

BBCNEWS BBC News January 28, 2022 19:19:00

The early data is showing that its spreading more quickly than the original version. they looked at contact tracing data and found that it was spreading a little bit more quickly within households. while growth advantage can fluctuate in the early data, thats why they are saying it is important to be cautious because this is really early data, they do think it has a substantial growth advantage. tt substantial growth advantage. it spreads more quickly? it substantial growth advantage. it| spread...
Contact Tracing Data Growth Advantage Genome Sequencing

BBCNEWS BBC News January 28, 2022 20:31:00

Thats why theyre saying its important to be cautious, because this is really early data, they do think it has a substantial growth advantage. it spreads more quickly. this is still early days and things may change as they learn more about it. the encouraging thing is the vaccines are still working, so after two or three go it says, its still providing protection against symptomatic disease for both variants. clearly, much more research is needed, but they say that the uk is in quite good positio...
Growth Advantage Board Infections Genome Sequencing Ta Ke Lets Takea Look

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science